Page last updated: 2024-10-26

dimercaprol and Immune System Diseases

dimercaprol has been researched along with Immune System Diseases in 2 studies

Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.

Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HASSELMANN, CM1
RICHTER, R1
BERGMANN, A1
EILLES, W1
JOHNE, HO1
Mas, M1
Cavaillès, P1
Colacios, C1
Subra, JF1
Lagrange, D1
Calise, M1
Christen, MO1
Druet, P1
Pelletier, L1
Gauguier, D1
Fournié, GJ1

Other Studies

2 other studies available for dimercaprol and Immune System Diseases

ArticleYear
[Experimental and clinical observations on necrosis of muscle following injection of BAL and sulfactin (Homburg), and its relation to the Sanarelli-Shwartzman phenomenon].
    Archiv fur Dermatologie und Syphilis, 1951, Volume: 192, Issue:6

    Topics: Dimercaprol; Humans; Hypersensitivity; Immune System Diseases; Muscles; Necrosis; Shwartzman Phenome

1951
Studies of congenic lines in the Brown Norway rat model of Th2-mediated immunopathological disorders show that the aurothiopropanol sulfonate-induced immunological disorder (Aiid3) locus on chromosome 9 plays a major role compared to Aiid2 on chromosome 1
    Journal of immunology (Baltimore, Md. : 1950), 2004, May-15, Volume: 172, Issue:10

    Topics: Animals; Animals, Congenic; Chromosome Mapping; Crosses, Genetic; Dimercaprol; Disease Models, Anima

2004